Genetic Technology News

摘要

UK Gives go Ahead for Human Cloning for Motor Neuron Research, Animal Models Respond to Parkinson 's Gene Therapy, Zymogenetics' Human Thrombin Phase II Results, GTN Strategic Partners,Some Important Patents for You To Check. INDIAN TRIAL FOR TARGETED GENETICS HTV VACCINE: Phase I clinical trials oftgAAC09, an HTV/AIDS vaccine, which is being developed by Targeted Genetics Corp., are underway in Germany amd Belgium under a collaborative international agreement (GTN4/4/03). Re-suits of these trials will be reported during the first half of this year. Now the program is being expanded with a Phase I clinical trial in India. The company is working with International AIDS Vaccine Initiative (IAVT), Indian Council of Medical Research (ICMR), National AIDS Control Organization (NACO), researchers at Columbus Children's Research Institute (CCRI) (Columbus, OH), and Children's Hospital of Philadelphia (CHOP). The goal is to develop a preventive vaccine to fight the global HIV/AIDS pandemic.